請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/65886
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 郭彥彬(Yen-Ping Kuo) | |
dc.contributor.author | Yi-Shin Tsai | en |
dc.contributor.author | 蔡怡欣 | zh_TW |
dc.date.accessioned | 2021-06-17T00:14:35Z | - |
dc.date.available | 2012-09-17 | |
dc.date.copyright | 2012-09-17 | |
dc.date.issued | 2012 | |
dc.date.submitted | 2012-07-06 | |
dc.identifier.citation | Aarthi JJ, Darendeliler MA, Pushparaj PN. (2011). Dissecting the role of the S1P/S1PR axis in health and disease. J Dent Res. 90, 841-854.
Abraham DJ, Shi-Wen X, Black CM, Sa S, Xu Y, Leask A. (2000). Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts. J Biol Chem. 275, 15220–15225. Abreu JG, Ketpura NI, Reversade B, De Robertis EM. (2002). Connectivetissue growth factor (CTGF) modulates cell signaling by BMP and TGF-beta. Nat Cell Biol. 4, 599–604. Ahn WS, Yoo J, Huh SW, Kim CK, Lee JM, Namkoong SE, et al. (2003). Protective effect of green tea extracts (polyphenon E and EGCG) on human cervical lesions. Eur J Cancer Prev. 12, 383–390. Babic AM, Chen CC, Lau LF. (1999). Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol Cell Biol. 19, 2958–2966. Ball DK, Moussad EE, Rageh MA, Kemper SA, Brigstock DR. (2003). Establishment of a recombinant expression system for connective tissue growth factor (CTGF) that models CTGF processing in vitro. Reproduction. 125, 271–284. Ball DK, Rachfal AW, Kemper SA, Brigstock DR.(2003). The heparinbinding 10 kDa fragment of connective tissue growth factor (CTGF) containing module 4 alone stimulates cell adhesion. J Endocrinol. 176, R1–7. Bork P. (1993). The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett. 327, 125–130. Bose KS, Vyas P, Singh M. (2012). Plasma non-enzymatic antioxidants-vitamin C, E, beta-carotenes, reduced glutathione levels and total antioxidant activity in oral sub mucous fibrosis. Eur Rev Med Pharmacol Sci. 16(4), 530-532. Brahma N. Singh a, Sharmila Shankar b, Rakesh K. Srivastava. (2011). Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications. Biochemical Pharmacology. 82, 1807–1821 Brigstock DR, Steffen CL, Kim GY, Vegunta RK, Diehl JR, Harding PA. (1997). Purification and characterization of novel heparin-binding growth factors in uterine secretory fluids. Identification as heparin-regulated Mr 10,000 forms of connective tissue growth factor. J Biol Chem. 272, 20275–20282. Chambers RC, Leoni P, Blanc-Brude OP, Wembridge DE, Laurent GJ. (2000). Thrombin is a potent inducer of connective tissue growth factor production via proteolytic activation of protease-activated receptor-1. J Biol Chem. 275, 35584–35591. Chang JZ, Yang WH, Deng YT, Chen HM, Kuo MY. (2011). Thrombin-stimulated connective tissue growth factor (CTGF/CCN2) production in human buccal mucosal fibroblasts: Inhibition by epigallocatechin-3-gallate. Head Neck. [Epub ahead of print] Chang JZ, Yang WH, Deng YT, Chen HM, Kuo MY. (2012). EGCG blocks TGFβ1-induced CCN2 by suppressing JNK and p38 in buccal fibroblasts. Clin Oral Investig. [Epub ahead of print] Chang YC, Yang SF, Tai KW, Chou MY, Hsieh YS. (2002). Increased tissue inhibitor metalloproteinase-1 expression and inhibition of gelatinase A activity in buccal mucosal fibroblasts by arecoline as possible mechanisms for oral submucous fibrosis. Oral Oncol. 38, 195–200. Chen CC, Chen N, Lau LF. (2001). The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts. J Biol Chem. 276, 10443–10452. Chen Y, Abraham DJ, Shi-Wen X, Pearson JD, Black CM, Lyons KM, et al. (2004). CCN2 (connective tissue growth factor) promotes fibroblast adhesion to fibronectin. Mol Biol Cell. 15, 5635–5346. Chen Y, Blom IE, Sa S, Goldschmeding R, Abraham DJ, Leask A. (2002). CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC. Kidney Int. 62, 1149–1159. Chen Y, Segarini P, Raoufi F, Bradham D, Leask A.(2001). Connective tissue growth factor is secreted through the Golgi and is degraded in the endosome. Exp Cell Res. 271, 109–117. Chen Y, Shi-wen X, Eastwood M, Black CM, Denton CP, Leask A, et al. (2006). Contribution of activin receptor-like kinase 5 (TGF-beta receptor type I) signaling to the fibrotic phenotype of scleroderma fibroblasts. Arthritis Rheum. 54, 1309–1316. Chen Y, Shi-Wen X, van Beek J, Kennedy L, McLeod M, Renzoni E, et al.(2005). Matrix contraction by dermal fibroblasts requires TGFb/ALK5, heparan sulfate containing proteoglycans and MEK/ERK: Insights into pathological scarring in chronic fibrotic disease. Am J Pathol. 167,1699–1711. Colwell AS, Phan T, Kong W, Longaker M, Lorenz P. Hypertrophic scar fibroblasts have increased connective tissue growth factor expression after TGF-beta stimulation. (2005). Plast Reconstr Surg. 116, 1387–1390. Cooper R, Morré DJ, Morré DM. (2005). Medicinal benefits of green tea: part I. review of noncancer health benefits. J Altern Complement Med. 3, 521-528. Cooper R, Morré DJ, Morré DM. (2005). Medicinal benefits of green tea: part II. review of anticancer properties. J Altern Complement Med. 4, 639-652. Dziadzio M, UsingerW, Leask A, Abraham D, Black CM, Denton C, et al. (2005). N-terminal connective tissue growth factor is a marker of the fibrotic phenotype in scleroderma. QJM. 98, 485–492. De Winter P, Leoni P, Abraham D. (2008). Connective tissue growth factor: structure-function relationships of a mosaic, multifunctional protein. Growth Factors. 26, 80–91. Deng YT, Chen HM, Cheng SJ, Chiang CP, Kuo YP. (2009). Arecoline-stimulated connective tissue growth factor production in human buccal mucosal fibroblasts: Modulation by curcumin. Oral Oncology. 45, 99–105. Fassina G, Buffa A, Benelli R, Varnier OE, et al. (2002). Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent. AIDS. 16, 939–941. Farrand P, Rowe RM, Johnston A, Murdoch H. (2001). Prevalence, age of onset and demographic relationships of different areca nut habits amongst children in Tower Hamlets, London. Br Dent J. 190, 150–154. Finckenberg P, Inkinen K, Ahonen J, Merasto S, Louhelainen M, Vapaatalo H, et al. (2003). Angiotensin II induces connective tissue growth factor gene expression via calcineurin-dependent pathways. Am J Pathol. 163, 355–366. Frazier K, Williams S, Kothapalli D, Klapper H, Grotendorst GR. (1996). Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol. 107, 404–411. Friedrichsen S, Heuer H, Christ S, Winckler M, Brauer D, Bauer K, et al. (2003). CTGF expression during mouse embryonic development. Cell Tissue Res. 312, 175–188. Hanafusa N, Yatomi Y, Yamada K et al. (2002). Sphingosine 1-phosphate stimulates rat mesangial cell proliferation from outside the cells. Nephrol Dial Transplant. 17, 580–586. Harvey W, Scutt A, Meghji S, Canniff P. (1986). Stimulation of human buccal mucosa fibroblasts in vitro by betel nut alkaloids. Arch Oral Biol. 31, 45–49. Haque MF, Meghji S, Khitab U, Harris M. (2000). Oral submucous fibrosis patients have altered levels of cytokine production. J Oral Pathol Med. 29, 123–128. Hla T (2004). Physiological and pathological actions of sphingosine 1-phosphate. Semin Cell Dev Biol. 15, 513-520. Hideru Obinata & Timothy Hla. (2012). Sphingosine 1-phosphate in coagulation and inflammation. Semin Immunopathol. 34, 73–91. Horstmeyer A, Licht C, Scherr G, Eckes B, Krieg T. Signalling and regulation of collagen I synthesis by ET-1 and TGF-β1. (2005). FEBS J. 272, 6297–6309. Igarashi A, Okochi H, Bradham DM, Grotendorst GR. (1993). Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell. 4, 637–645. International Agency for Research on Cancer. (2004). Betel-quid and areca nut chewing and some areca nut derived nitrosoamines. IARC. 85, 123–129. Isbrucker RA, Edwards JA, Wolz E, Davidovich A, Bausch J. (2006). Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies. Food Chem Toxicol. 44(5), 636-650. Ivkovic S, Yoon BS, Popoff SN et al. (2003). Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development. 130, 2779–2791. Jacob BJ, Straif K, Thomas G, Ramadas K, Mathew B, Zhang ZF, et al. (2004). Betel quid without tobacco as a risk factor for oral precancers. Oral Oncol. 40, 697–704. Jenne CN, Enders A, Rivera R, Watson SR, Bankovich AJ, Pereira JP, et al. (2009). T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow. J Exp Med. 206, 2469-2481. Joshi SG (1953). Submucous fibrosis of palate and pillars. Indian J Otolaryngol. 4, 1. Kagen HM, Trackenman PC. (1991). Properties and function of lysyl oxidase. Am J Respir Cell Mol Biol. 5, 206–210. Karwan AM, Veronika J, Karen S, Daniel M, Paul HW, Shelia MV, et al. (2010). Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis. J Pathol. 223(3), 366-377. Katiyar SK, Afaq F, Perez A. (2001). Green tea polyphenol(-)–epigallocatechin- 3–gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress. Carcinogenesis. 22, 287–294. Kawai K, Tsuno NH, Kitayama J, Okaji Y, et al. (2003). Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding. J Allergy Clin Immunol. 112, 951–957. Khan N, Afaq F, Saleem M, Ahmad N, Mukhtar H. (2006). Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res. 66, 2500–2505. Kirby RJ, Jin Y, Fu J e t al. (2009). Dynamic regulation of sphingosine-1-phosphate homeostasis during development of mouse metanephric kidney. Am J Physiol Renal Physiol. 296, 634–641. Kono Y, Nishiuma T, Nishimura Y, Kotani Y, Okada T, Nakamura S, Yokoyama M. (2007).Sphingosine kinase 1 regulates differentiation of human and mouse lung fibroblasts mediated by TGF-beta1. Am J Respir Cell Mol Biol. 37(4),395-404. Leask A, Abraham DJ.(2003). The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology. Biochem Cell Biol. 81, 355–363. Leask A, Abraham DJ, Finlay DR, Holmes A, Pennington D, Shi-Wen X, et al. (2002). Dysregulation of transforming growth factor beta signaling in scleroderma: overexpression of endoglin in cutaneous scleroderma fibroblasts. Arthritis Rheum. 46, 1857–1865. Lee JF, Zeng Q, Ozaki H, Wang L, Hand AR, Hla T, et al. (2006b). Dual roles of tight junction-associated protein, zonula occludens-1, in sphingosine 1-phosphate- mediated endothelial chemotaxis and barrier integrity. J Biol Chem. 281, 29190- 29200. Lee MJ, Thangada S, Claffey KP, Ancellin N, Liu CH, Kluk M, et al. (1999). Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell. 99, 301-312. Lee SS, Tsai CH, Ho YC, Yu CC, Chang YC. (2012). Heat shock protein 27 expression in areca quid chewing-associated oral squamous cell carcinomas. Oral Dis. [Epub ahead of print] Li C, Jiang X, Yang L, Liu X, Yue S, Li L (2009a). Involvement of sphingosine 1-phosphate (SIP)/S1P3 signaling in cholestasis-induced liver fibrosis. Am J Pathol. 175, 1464-1472. Li C, Kong Y, Wang H, Wang S, Yu H, Liu X, et al. (2009b). Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis. J Hepatol. 50, 1174-1183. Li C, Zheng S, You H, Liu X, Lin M, Yang L, Li L. (2011). Sphingosine 1-phosphate (S1P)/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motility. J Hepatol. 54(6), 1205-1213. Maher R, Lee AJ, Warnakulasuriya KA, Lewis JA, Johnson NW. (1994). Role of areca nut in the causation of oral submucous fibrosis: a case control study in Pakistan. J Oral Pathol Med. 23, 65–69. Ma RH, Tsai CC, Shieh TY. (1995). Increased lysyl oxidase activity in fibroblasts cultured from oral submucous fibrosis associated with betel nut chewing in Taiwan. J Oral Pathol Med. 24, 407–412. Mathew AL, Pai KM, Sholapurkar AA, Vengal M. (2008). The prevalence of oral mucosal lesions in patients visiting a dental school in Southern India. Indian J Dent Res. 19, 99–103. McVerry BJ, Garcia JG (2004). Endothelial cell barrier regulation by sphingosine 1-phosphate. J Cell Biochem. 92, 1075-1085. McVerry BJ, Garcia JG (2005). In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: mechanistic insights. Cell Signal. 17, 131-139. Meghji S, Scutt A, Canniff JP, Harvey W, Phillipson JD. (1982). Inhibition of collagenase activity by areca nut tannins: a mechanism of collagen accumulation in oral submucous fibrosis? J Dent Res. 61,545. Meghji S, Scutt A, Harvey W, Canniff JP. (1987). An in vitro comparison of human fibroblasts from normal and oral submucous fibrosis tissue. Arch Oral Biol. 32, 213–215. Melendez AJ, Harnett MM, Pushparaj PN, Wong WS, Tay HK, McSharry CP, et al. (2007). Inhibition of Fc epsilon RI-mediated mast cell responses by ES-62, a product of parasitic filarial nematodes. Nat Med. 13, 1375-1381. Merchant AT, Haider SM, Fikree FF. (1997). Increased severity of oral submucous fibrosis in young Pakistani men. Br J Oral Maxillofac Surg. 35, 284–287. Milara J, Navarro R, Juan G, Peiró T, Serrano A, Ramón M, Morcillo E, Cortijo J. (2012). Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal transition. Thorax. 67(2), 147-56. Mori T, Kawara S, Shinozaki M, Hayashi N, Kakinuma T, Igarashi A, et al.(1999). Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: a mouse fibrosis model. J Cell Physiol. 181, 153–159. Murphy M, Godson C, Cannon S, Kato S, Mackenzie HS, Martin F, et al. (1999). Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem. 274, 5830–5834. Murti PR, Bhonsle RB, Gupta PC, Daftary DK, Pindborg JJ, Metha FS. (1995). Aetiology of oral submucous fibrosis with special reference to the role of areca nut chewing. J Oral Pathol Med. 24,145–152. Murti PR, Bhonsle RB, Pindborg JJ, Daftary DK, Gupta PC, Mehta FS. (1985). Malignant transformation rates in oral submucous fibrosis over a 17 year period. Community Dent Oral Epidemiol. 13, 340–341. Narayanan AS, Meyers DF, Page RC, Welgus HG. (1984). Action of mammalian collagenase of type I trimer collagen. Collagen Rel Res. 4, 289–296. Nayak D, Huo Y, Kwang WX, Pushparaj PN, Kumar SD, Ling EA, et al. (2010). Sphingosine kinase 1 regulates the expression of proinflammatory cytokines and nitric oxide in activated microglia. Neuroscience. 166, 132-144. Nishida T, Kubota S, Fukunaga T, Kondo S, Yosimichi G, Nakanishi T, et al. (2003). CTGF/Hcs24, hypertrophic chondrocyte-specific gene product, interactswith perlecan in regulating the proliferation and differentiation of chondrocytes. J Cell Physiol. 196, 265–327. Paradis V, Dargere D, Vidaud M, De Gouville AC, Huet S, Martinez V, et al. (1999). Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology. 30, 968–976. Pan LH, Yamauchi K, Uzuki M, Nakanishi T, Takigawa M, Inoue H, et al. (2001). Type II alveolar epithelial cells and interstitial fibroblasts express connective tissue growth factor in IPF. Eur Respir J. 17,1220–1227. Perbal B. (2004).CCN proteins: multifunctional signalling regulators. Lancet. 363, 62–64. Phanish MK, Winn SK, Dockrell ME. (2010). Connective tissue growth factor-(CTGF, CCN2)--a marker, mediator and therapeutic target for renal fibrosis. Nephron Exp Nephrol. 114(3), e83-92. Ranganathan K, Uma Devi M, Joshua E, Kirankumar K, Saraswathi TR. (2004). Oral submucous fibrosis: a case control study in Chennai South India. J Oral Pathol Med. 33, 274–277. Ren S, Babelova A, Moreth K et al. (2009). Transforming growth factor-ß2 upregulates sphingosine kinase-1 activity, which in turn attenuates the fibrotic response to TGF-ß2 by impeding CTGF expression. Kidney Int. 76, 857–867. Revant HC, Shailesh MG, Amol RG, Swati B, Sudesh C, Snehal VD, et al. (2011). Review of drug treatment of oral submucous fibrosis. Oral oncology. Article in press. Sanchez T, Hla T. (2004). Structural and functional characteristics of S1P receptors. J Cell Biochem. 92(5) ,913-922. Sartippour MR, Shao ZM, Heber D, Beatty P, Zhang L, Liu C, et al. (2002). Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells. J Nutr. 132, 2307–2311. Schober JM, Chen N, Grzeszkiewicz TM, Jovanovic I, Emeson EE, Ugarova TP, et al. (2002). Identification of integrin alpha(M)beta(2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions. Blood. 99, 4457–4465. Scutt A, Meghji S, Canniff JP, Harvey W. (1987). Stabilisation of collagen by betel nut polyphenols as a mechanism in oral submucous fibrosis. Experientia. 43, 391–393. Seedat HA, Van Wyk CW. (1988). Betel nut chewing and oral submucous fibrosis in Durban. S Afr Med J. 74, 572–575. Shah N, Sharma PP. (1998). Role of chewing and smoking habits in the aetiology of oral submucous fibrosis (OSF): a case control study. J Oral Pathol Med. 27, 475–479. Shieh DH, Chiang LC, Shieh TY. (2003). Augmented mRNA expression of tissue inhibitor of metalloproteinase1 in buccal mucosal fibroblasts by arecoline and safrole as a possible pathogenesis for oral submucous fibrosis. Oral Oncol. 39, 728–735. Shieh DH, Chiang LC, Lee CH, Yang YH, Shieh TY. (2004). Effects of arecoline, safrole and nicotine on collagen phagocytosis by human buccal mucosal fibroblasts as a possible mechanism for oral submucous fibrosis in Taiwan. J Oral Pathol Med. 33, 581–587. Shieh TY, Yang JF. (1992). Collagenase activity in oral submucous fibrosis. Pro Natl Sci Counc China B. 16, 106–110. Shi-Wen X, Howat SL, Renzoni E, Pearson JD, Dashwood MR, Denton CP, et al. (2004). Endothelin-1 induces expression of matrix-associated genes in lung fibroblasts through MEK/ERK. J Biol Chem. 279, 23098–23103. Shi-Wen X, Leask A, Abraham D. (2008). Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev. 19, 133–144. Shi-Wen X, Pennington D, Holmes A, Leask A, Bradham D,Beauchamp JR, et al. (2000). Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis. Exp Cell Res. 259, 213–224. Shi-Wen X, Stanton LA, Kennedy L, Pala D, ChenY, Howat SL, et al. (2006). CCN2 is necessary for adhesive responses to transforming growth factor-beta1 in embryonic fibroblasts. J Biol Chem. 281, 10715–10726. Singh BN, Shankar S, Srivastava RK. (2011). Green tea catechin, epigallocatechin-3- gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol. 82(12), 1807- 1821. Sinor PN, Gupta PC, Murti PR, Bhonsle RB, Daftary DK, Mehta FS, et al. (1990). A case-control study of oral submucous fibrosis with special reference to the aetiologic role of areca nut. J Oral Pathol Med. 19, 94–98. Slee RB, Hillier SG, Largue P, Harlow CR, Miele G, Clinton M. (2001). Differentiation-dependent expression of connective tissue growth factor and lysyl oxidase messenger ribonucleic acids in rat granulose cells. Endocrinology. 142, 1082–1089. Spiegel S, Cuvillier O, Edsall L, Kohama T, Menzeleev R, Olivera A, et al. (1998a). Roles of sphingosine-1-phosphate in cell growth, differentiation, and death. Biochemistry (Mosc). 63, 69-73. Spiegel S, Cuvillier O, Edsall LC, Kohama T, Menzeleev R, Olah Z, et al. (1998b). Sphingosine-1-phosphate in cell growth and cell death. Ann NY Acad Sci. 845, 11-18. Spiegel S, Milstien S. (2003). Sphingosine-1-phosphate: an enigmatic signaling lipid. Nat Rev Mol Cell Biol. 4, 397-407. Stratton R, Rajkumar V, Ponticos M, Nichols B, Shi-Wen X, Black CM, et al. (2002). Prostacyclin derivatives prevent the fibrotic response toTGF-beta by inhibiting the Ras/MEK/ERK pathway. FASEB J. 16, 1949–1951. Surveyor GA,Wilson AK, Brigstock DR.(1998). Localization of connective tissue growth factor during the period of embryo implantation in the mouse. Biol Reprod. 59, 1207–13. Suvi-Katri Leivonen, Lari Hakkinen, David Liu, and Veli-Matti Kahari. (2005). Smad3 and Extracellular Signal-Regulated Kinase 1/2 Coordinately Mediate Transforming Growth Factor-β-Induced Expression of Connective Tissue Growth Factor in Human Fibroblasts. J Invest Dermatol. 124, 1162 –1169. Takabe K, Paugh SW, Milstien S, Spiegel S (2008). “Inside-out” signaling of sphingosine-1-phosphate: therapeutic targets. Pharmacol Rev. 60, 181-195. Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S. (2006). Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncology. 42, 561–568. Tipoe GL, Leung TM, Hung MW, Fung ML. (2007). Green tea polyphenols as an anti-oxidant and anti-inflammatoryagent for cardiovascular protection. Cardiovasc Hematol Disord Drug Targets. 7, 135–44. Trivedy CR, Warnakulasuriya KAAS, Hazarey VK, Tavassoli M, Sommer P, Johnson NW. (1999). The upregulation of lysyl oxidase in oral submucous fibrosis and squamous cell carcinoma. J Oral Med Pathol. 28, 246–251. Trivedy C, Warnakulasuriya KAAS, Johnson NW, Peters TJ. (1997). Copper content in areca catechu products and oral submucous fibrosis. Lancet. 340, 1447. Trivedy CR, Warnakulasuriya KAAS, Peters TJ, Senkus R, Hazarey VK, Johnson NW. (2000). Raised tissue copper levels in oral submucous fibrosis. J Oral Pathol Med. 29, 241–248. Trivedy CR, Craig G, Warnakulasuriya S (2002). The oral health consequences of chewing areca nut. Addict Biol. 7, 115. Tsai CC, Ma RH, Shieh TY. (1999). Deficiency in collagen and fibronectin phagocytosis by human buccal mucosa fibroblasts in vitro as a possible mechanism for oral submucous fibrosis. J Oral Pathol Med. 28,59–63. Uchio K, Graham M, Dean NM, Rosenbaum J, Desmouliere. (2004). A.Down-regulation of connective tissue growth factor and type I collagen mRNA expression by connective tissue growth factor antisense oligonucleotide during experimental liver fibrosis. Wound Repair Regen. 12, 60–66. Utsunomiya H, Tilakaratne WM, Oshiro K, Maruyama S, Suzuki M, Ida-Yonemochi M, et al. (2005). Extracellular matrix remodeling in oral submucous fibrosis; its stage- specific modes revealed by immuno-histochemistry and in-situ hybridization. J Oral Pathol Med. 34, 498–507. Van Beek JP, Kennedy L, Rockel JS, Bernier SM, Leask A. (2006). The induction of CCN2 by TGFbeta1 involves Ets-1. Arthritis Res Ther. 8, R36. Walzer T, Chiossone L, Chaix J, Calver A, Carozzo C, Garrigue-Antar L,et al. (2007). Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nat Immunol. 8, 1337-1344. Xin C , Ren S , Kleuser B et al. (2004). Sphingosine 1-phosphate cross-activates the Smad signaling cascade and mimics transforming growth factor-ß induced cell responses. J Biol Chem. 279, 35255 – 35262 . Yamaguchi K, Honda M, Ikigai H, Hara Y, Shimamura T. (2002). Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1). Antiviral Res. 53, 19–34. Yamamoto Y, Furukawa K, Ueyama K, Nakanishi T, Takigawa M, Harata S. (2002). Possible roles of CTGF/Hcs24 in the initiation and development of ossification of the posterior longitudinal ligament. Spine. 27, 1852–1857. Yang L, Chang N, Liu X, Han Z, Zhu T, Li C, Yang L, Li L.(2012). Bone Marrow-Derived Mesenchymal Stem Cells Differentiate to Hepatic Myofibroblasts by Transforming Growth Factor-β1 via Sphingosine Kinase/Sphingosine 1-Phosphate (S1P)/S1P Receptor Axis. Am J Pathol. [Epub ahead of print] Yang YH, Lee HY, Tung S, Shieh TY. (2001). Epidemiological survey of oral submucous fibrosis and leukoplakia in aborigines of Taiwan. J Oral Pathol Med. 30, 213–219. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/65886 | - |
dc.description.abstract | 結締組織生長因子 (connective tissue growth factor,CTGF) 與許多人類的疾病,如肺臟、肝臟、腎臟及牙齦的纖維化有關,在這些疾病中CTGF都有增加的情況。目前認為導致口腔黏膜下纖維化症 (oral submucous fibrosis,OSF) 的主因為檳榔中的檳榔素 (arecoline) 和檳榔中的粗糙纖維在嚼食的過程中對頰黏膜所造成的物理性創傷長時間慢性刺激口腔黏膜所形成。先前的研究也指出檳榔素可刺激人類頰黏膜纖維母細胞 (human buccal mucosa fibroblasts) 大量表現CTGF,且嚼食檳榔者其組織切片的免疫螢光化學染色也可見到有大量CTGF的表現。
鞘氨醇磷酸脂 (Sphingosine-1-phosphate,S1P) 是一種低分子量的溶血磷脂質 (lysophopholipid,LPL) ,由血小板製造,在傷口癒合的過程中會被血小板釋放至受傷的組織內,具有減少血管通透性進而達到穩定血管的作用,近來的研究顯示特發性肺纖維化 (idiopathic pulmonary fibrosis, IPF) 的病人S1P有顯著的增加,除此之外S1P也與腎臟及肝臟的纖維化有關。在嚼食檳榔的過程中對頰黏膜所造成的物理性創傷吸引血小板的聚集並且釋放出S1P, 可能與口腔黏膜下纖維化症的形成有關。 本研究發現人類頰黏膜纖維母細胞在S1P的刺激下,具有隨濃度及時間表現CTGF的特性,JNK抑制劑SP600125可以抑制S1P誘發CTGF的表現,綠茶中的茶多酚EGCG可藉由抑制JNK pathway來達到抑制S1P誘發頰黏膜纖維母細胞的CTGF表現。期望未來可以利用EGCG,藉由抑制CTGF的表現來治療或抑制口腔黏膜下纖維化症的發生及進展。 | zh_TW |
dc.description.abstract | Connective tissue growth factor (CTGF) overexpression has been widely shown to be associated with many human diseases such as pulmonary, renal, hepatic, and gingival fibrosis. OSF is the result of persistent chemical irritation and microtrauma to oral mucosa from areca nut (AN). Previous immunohistochemical studies showed overexpression of CTGF protein in OSF tissues. In vitro study showed that arecoline enhanced CTGF expression in normal buccal mucosa fibroblasts.
Sphingosine-1-phosphate (S1P) is a low-molecular weight lysophospholipid (LPL) stored in platelets. S1P is released by platelets upon stimulation and was engaged in wound healing and coagulation process by decreasing vascular permeability and enhancing vascular stabilization. S1P is elevated in patients with IPF (idiopathic pulmonary fibrosis), correlates with the lung function and mediates EMT (epithelial to mesenchymal transition). Recent evidence suggests that S1P also plays an important role in renal fibrosis, pulmonary fibrosis and liver fibrosis. Microtrauma could lead to the release of S1P. In our study, S1P can induce CTGF overexpression in normal buccal mucosa fibroblasts in a time- and dose-dependent manner and can be inhibited by JNK inhibitor SP600125. We also find green tea extracts, EGCG, can down-regulate CTGF expression by attenuating JNK pathway. In the future, our expectation is to find out a drug that can reverse or inhibit the fibrotic process during the development of oral submucous fibrosis. | en |
dc.description.provenance | Made available in DSpace on 2021-06-17T00:14:35Z (GMT). No. of bitstreams: 1 ntu-101-R99422012-1.pdf: 2161669 bytes, checksum: d506084dc9e0980d2797d987d5bbfba4 (MD5) Previous issue date: 2012 | en |
dc.description.tableofcontents | 口試委員會審定書 #
誌謝 i 中文摘要 ii ABSTRACT iii 目錄 iv 導論 1 第一節 口腔黏膜下纖維化 1 1-1 口腔黏膜下纖維化的簡介 1 1-2 口腔黏膜下纖維化的流行病學 1 1-3 口腔黏膜下纖維化的致病機轉 2 1-4 口腔黏膜下纖維化的治療方式 5 第二節 傷口癒合 6 第三節 鞘氨醇磷酸脂 (Sphingosine-1-phosphate,S1P) 8 3-1 S1P的簡介 8 3-2 S1P的訊息傳遞路徑 9 3-3 S1P與纖維化 11 第四節 結締組織生長因子 (Connective tissue growth factor, CTGF) 13 4-1 CTGF的簡介 13 4-2 CTGF的訊息傳遞路徑 14 4-3 CTGF與纖維化 15 第五節 綠茶多酚 (Epigallocatechin-3-gallate,EGCG) 18 實驗目的 20 實驗材料與方法 21 第一節 細胞株與細胞培養 21 第二節 藥物處理 22 第三節 西方墨點法 23 結果 27 S1P可以誘導人類口腔頰黏膜纖維母細胞表現CTGF蛋白 27 JNK、ERK、Smad3、ALK5抑制劑會抑制S1P誘導之人類頰黏膜纖維母細胞CTGF的表現量 27 綠茶多酚(EGCG)可以減少人類頰黏膜纖維母細胞在S1P誘導下的CTGF表現量 28 討論與未來展望 29 結論 30 圖與表 31 REFERENCE 39 | |
dc.language.iso | zh-TW | |
dc.title | 綠茶多酚EGCG抑制Sphingosine 1-Phosphate 誘導頰黏膜纖維母細胞 CTGF 表現之研究 | zh_TW |
dc.title | Sphingosine 1-Phosphate Stimulated Connective Tissue Growth Factor in Oral Mucosal Fibroblasts: Modulation by EGCG | en |
dc.type | Thesis | |
dc.date.schoolyear | 100-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 江俊斌,張龍昌 | |
dc.subject.keyword | 口腔黏膜下纖維化症,鞘氨醇磷酸脂,結締組織生長因子,綠茶多酚, | zh_TW |
dc.subject.keyword | oral submucous fibrosis,sphingosine-1-phosphate,connective tissue growth factor,epigallocatechin-3-gallate, | en |
dc.relation.page | 51 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2012-07-06 | |
dc.contributor.author-college | 牙醫專業學院 | zh_TW |
dc.contributor.author-dept | 臨床牙醫學研究所 | zh_TW |
顯示於系所單位: | 臨床牙醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-101-1.pdf 目前未授權公開取用 | 2.11 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。